Anthony J Dalby Selected Research

Anthony J Dalby Research Topics

Disease

17	Myocardial Infarction 01/2022 - 11/2005
14	Hemorrhage 01/2021 - 10/2008
11	Acute Coronary Syndrome 01/2022 - 04/2009
11	Stroke (Strokes) 01/2021 - 04/2012
4	Heart Failure 01/2022 - 11/2005
4	Coronary Disease (Coronary Heart Disease) 01/2022 - 05/2014
4	Ischemic Stroke 01/2022 - 04/2012
4	Diabetes Mellitus 01/2021 - 10/2008
3	Ischemia 04/2012 - 04/2009
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2021
2	Unstable Angina 01/2022 - 10/2012
2	Atrial Fibrillation 01/2022 - 10/2013
2	Atherosclerotic Plaque (Atheroma) 01/2020 - 05/2014
2	Hemorrhagic Stroke 12/2017 - 09/2016
2	Atherosclerosis 03/2015 - 04/2012
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Dyspnea (Shortness of Breath) 07/2016
1	Thrombosis (Thrombus) 08/2015
1	Transient Ischemic Attack 03/2015
1	Chronic Renal Insufficiency 10/2013
1	Body Weight (Weight, Body) 08/2013
1	Prediabetic State (Prediabetes) 06/2013
1	Peripheral Arterial Disease 04/2012
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 04/2012
1	Hypercholesterolemia 06/2011
1	ST Elevation Myocardial Infarction 06/2011
1	Hypertension (High Blood Pressure) 06/2011
1	Left Ventricular Dysfunction 11/2005

Drug/Important Bio-Agent (IBA)

6	Prasugrel Hydrochloride FDA Link 06/2017 - 10/2008
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 08/2013
5	Clopidogrel (Plavix)FDA Link 06/2017 - 10/2008
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 11/2017
3	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2020
3	TicagrelorIBA 01/2021 - 07/2016
3	darapladibIBA 01/2020 - 05/2014
3	vorapaxarIBA 03/2015 - 04/2012
2	alirocumabIBA 01/2022 - 01/2019
1	dapagliflozinIBA 01/2022
1	LDL CholesterolIBA 01/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2020
1	Lipoproteins (Lipoprotein)IBA 01/2019
1	oxidized low density lipoproteinIBA 01/2019
1	Simvastatin (Zocor)FDA LinkGeneric 12/2017
1	Ezetimibe (Zetia)FDA Link 12/2017
1	Simvastatin Drug Combination Ezetimibe (Vytorin)FDA Link 12/2017
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 06/2017
1	Thrombin Receptors (Thrombin Receptor)IBA 03/2015
1	EnzymesIBA 05/2014
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 05/2014
1	AnticoagulantsIBA 10/2013
1	Warfarin (Coumadin)FDA LinkGeneric 10/2013
1	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2013
1	Streptokinase FDA Link 09/2013
1	Eptifibatide (Integrilin)FDA Link 09/2013
1	Glucose (Dextrose)FDA LinkGeneric 06/2013
1	Hemoglobins (Hemoglobin)IBA 06/2013
1	CreatinineIBA 06/2011
1	Glycoproteins (Glycoprotein)IBA 06/2011
1	Neurofibromin 2 (Merlin)IBA 04/2009
1	Ranolazine FDA Link 04/2009
1	Angiotensin Receptor AntagonistsIBA 11/2005
1	Captopril (Capoten)FDA LinkGeneric 11/2005
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2005
1	Valsartan (Vals)FDA Link 11/2005

Therapy/Procedure

14	Therapeutics 01/2022 - 11/2005
3	Percutaneous Coronary Intervention 01/2021 - 09/2013
3	Secondary Prevention 09/2016 - 03/2015
1	Surgical Amputation (Amputations) 01/2022
1	Stents 08/2015